A Covid vaccine researcher claims she was silenced for years right before warning the public about the dangers to certain ...
Sanofi CEO Paul Hudson reports a decline in U.S. vaccine demand due to misinformation and policy changes from the Trump ...
New Jersey is breaking away from the federal Centers for Disease Control and Prevention's pared-down vaccine recommendations ...
Buying vaccine biotech Dynavax was an easy choice for Sanofi despite antivaccine moves by the Trump administration.
Sanofi Chief Executive Paul Hudson said on Wednesday the company is likely to see some weakness in U.S. vaccine demand this ...
Boxes of the Pfizer-BioNTech Covid-19 vaccine and Seqirus Fluad adjuvanted flu shot are kept in cold storage during an ...
Anthony Fauci privately acknowledged “impressive data” showed stronger immunity from a COVID-19 infection than vaccination ...
Clinical Trials Arena on MSN
JPM26: BioNTech gears up for multiproduct oncology status by 2030
Set for multiple late-stage readouts in oncology in 2026, BioNTech is entering a crucial phase of its roadmap beyond Covid-19 ...
MedPage Today on MSN
Flu antiviral use among hospitalized kids fell during COVID pandemic
Among 1,560 kids hospitalized with the flu, antiviral use ranged between 48.3% and 56.8% in the years before the pandemic, ...
The letter from medical groups and public health organizations urged lawmakers to prove "why the schedule was changed, why credible scientific evidence was ignored, and why the committee charged with ...
Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...
Pfizer Inc. (NYSE: PFE) is included among the 13 Best Dividend Stocks Paying Over 6%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results